Actively Recruiting
Fluciclovine PET/CT in Multiple Myeloma Patients
Led by Oslo University Hospital · Updated on 2019-05-30
10
Participants Needed
1
Research Sites
517 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients
CONDITIONS
Official Title
Fluciclovine PET/CT in Multiple Myeloma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Multiple myeloma patients suitable for ASCT treatment
You will not qualify if you...
- Patients with contraindications to ASCT treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oslo University Hosptal
Oslo, Norway, 0424
Actively Recruiting
Research Team
M
Mona-Elisabeth Revheim, MD, PhD, MHA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here